Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Edgewise Therapeutics, Inc.(EWTX) | 5,350,000 | 5,350,000 | 0 | $217.37M | $217.21M | 14.58% | -$160.5K |
| Asml Holding N VN Y REGISTRY SHS N Y REGISTRY SHS | 94,946 | 94,946 | 0 | $188.89M | $172.01M | 11.55% | -$16.88M |
| Brookfield CorporationCL A(BN) | 3,496,245 | 4,465,035 | +968,790 | $149.53M | $162.80M | 10.93% | +$13.26M |
| Hemab Therapeutics Hldgs Inc | 4,180,550 | 4,180,550 | 0 | $153.55M | $128.93M | 8.65% | -$24.62M |
| Avalyn Pharmaceuticals Inc | 3,883,289 | 3,449,191 | -434,098 | $127.84M | $98.27M | 6.60% | -$29.57M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 1,125,000 | 1,125,000 | 0 | $131.70M | $96.17M | 6.46% | -$35.54M |
| Salesforce, Inc.(CRM) | 393,187 | 393,187 | 0 | $61.60M | $90.26M | 6.06% | +$28.67M |
| Enliven Therapeutics Inc | 1,000,000 | 1,000,000 | 0 | $50.75M | $45.84M | 3.08% | -$4.91M |
| 4d Molecular Therapeutics In | 3,249,178 | 3,000,000 | -249,178 | $43.21M | $42.93M | 2.88% | -$284.1K |
| Obsidian Therapeutics Inc | 0 | 3,123,992 | +3,123,992 | $0 | $42.89M | 2.88% | +$42.89M |
| Vaxcyte, Inc.(PCVX) | 800,000 | 710,000 | -90,000 | $46.50M | $40.40M | 2.71% | -$6.11M |
| Floor & Decor Holdings, Inc.CL A(FND) | 797,000 | 797,000 | 0 | $47.31M | $36.51M | 2.45% | -$10.80M |
| Viridian Therapeutics, Inc.(VRDN) | 2,135,000 | 1,750,000 | -385,000 | $39.22M | $36.03M | 2.42% | -$3.19M |
| Arrivent Biopharma Inc | 1,500,000 | 1,175,000 | -325,000 | $52.11M | $35.58M | 2.39% | -$16.53M |
| Insmed Incorporated(INSM) | 120,723 | 284,425 | +163,702 | $12.87M | $32.46M | 2.18% | +$19.59M |
| Pharvaris N V COM | 1,400,000 | 1,019,426 | -380,574 | $48.41M | $32.34M | 2.17% | -$16.08M |
| Celldex Therapeutics, Inc.(CLDX) | 1,025,000 | 950,000 | -75,000 | $38.14M | $30.79M | 2.07% | -$7.35M |
| Alibaba Group Holding LimitedADS(BABA) | 257,327 | 257,327 | 0 | $24.70M | $27.67M | 1.86% | +$2.97M |
| Xenon Pharmaceuticals Inc.(XENE) | 485,438 | 652,105 | +166,667 | $29.30M | $24.25M | 1.63% | -$5.05M |
| Scholar Rock Holding Corporation(SRRK) | 0 | 460,002 | +460,002 | $0 | $22.23M | 1.49% | +$22.23M |
| Dyne Therapeutics, Inc.(DYN) | 960,394 | 1,376,164 | +415,770 | $21.33M | $22.17M | 1.49% | +$839.7K |
| Maplight Therapeutics Inc | 3,686,622 | 2,086,622 | -1,600,000 | $132.13M | $21.26M | 1.43% | -$110.87M |
| Contineum Therapeutics IncCL A | 0 | 704,013 | +704,013 | $0 | $9.45M | 0.63% | +$9.45M |
| Alumis Inc | 1,100,000 | 1,250,000 | +150,000 | $30.95M | $9.24M | 0.62% | -$21.72M |
| Bridgebio Oncology Therapeut | 2,250,000 | 2,250,000 | 0 | $17.14M | $9.22M | 0.62% | -$7.92M |
| Marqeta, Inc.CL A(MQ) | 441,558 | 110,389 | -331,169 | $7.17M | $1.88M | 0.13% | -$5.29M |
| Lanzatech Global Inc | 158,148 | 158,148 | 0 | $1.08M | $903.0K | 0.06% | -$175.5K |
| Crinetics Pharmaceuticals In | 1,320,000 | 0 | -1,320,000 | $49.39M | $0 | — | -$49.39M |